Roy Freeman, M.D.

Roy Freeman, M.D.

DirectoratInhibikase Therapeutics· In proxies 2023–2025

Roy Freeman, M.D. sits on 4 public boards.

Boards1

  • Inhibikase TherapeuticsDirector · 3 yr on the boardIndependentCompensation—Paid as an executive

Board seats come from each company's latest proxy statement.

Experience

  1. Inhibikase TherapeuticsPublic company · 3 yr
    • Director2023 – Present · 3 yrStock in role -41%
  2. Clinical Autonomic ResearchPublic company
    • Director? – PresentNo stock prices for these years
  3. Cutaneous Neurodiagnostic Life SciencesPublic company
    • Director? – PresentNo stock prices for these years
  4. Journal of the Peripheral Nervous SystemPublic company
    • Director? – PresentNo stock prices for these years

Roles come from the proxy statements of each company.

Activity

No new filings about this person in the feed.

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?